IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing targeted immunotherapies for cancer.
Industry: Health Care
Latest Trade: $1.96 0.00 (0.0%)
First Day Return: -10.8%
Return from IPO: -60.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/11/2022 |
Offer Price | $5.00 |
Price Range $5.00 - $7.00 | |
Offer Shares (mm) | 2.0 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/27/2022 |
Offer Price | $5.00 |
Price Range $5.00 - $7.00 | |
Offer Shares (mm) | 2.0 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
ThinkEquity |
Company Data | |
---|---|
Headquarters | Chicago, IL, United States |
Founded | 2018 |
Employees | 12 |
Website www.MAIABiotech.com |